CN114470069A - 一种养生中药组合物 - Google Patents
一种养生中药组合物 Download PDFInfo
- Publication number
- CN114470069A CN114470069A CN202210245860.6A CN202210245860A CN114470069A CN 114470069 A CN114470069 A CN 114470069A CN 202210245860 A CN202210245860 A CN 202210245860A CN 114470069 A CN114470069 A CN 114470069A
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- extracted
- health
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 22
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 239000000284 extract Substances 0.000 claims abstract description 152
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 18
- 241000007126 Codonopsis pilosula Species 0.000 claims abstract description 17
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 17
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 17
- 241000972672 Phellodendron Species 0.000 claims abstract description 15
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 14
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 14
- 235000020230 cinnamon extract Nutrition 0.000 claims abstract description 14
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 14
- 235000009467 Carica papaya Nutrition 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 13
- 241000132012 Atractylodes Species 0.000 claims abstract description 12
- 241000005787 Cistanche Species 0.000 claims abstract description 12
- 235000019206 astragalus extract Nutrition 0.000 claims abstract description 12
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 11
- 235000011477 liquorice Nutrition 0.000 claims abstract description 11
- 210000000582 semen Anatomy 0.000 claims abstract description 11
- 229940000492 pawpaw extract Drugs 0.000 claims abstract description 9
- 241000208340 Araliaceae Species 0.000 claims abstract description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 6
- 235000008434 ginseng Nutrition 0.000 claims abstract description 6
- 235000006533 astragalus Nutrition 0.000 claims abstract description 5
- 235000006264 Asimina triloba Nutrition 0.000 claims abstract description 4
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract description 4
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 4
- 244000189799 Asimina triloba Species 0.000 claims abstract 2
- 240000007371 Cuscuta campestris Species 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- 229940069445 licorice extract Drugs 0.000 claims description 6
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 3
- 239000009724 Salvia extract Substances 0.000 claims description 3
- 229940010454 licorice Drugs 0.000 claims description 3
- 241000045403 Astragalus propinquus Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 31
- 230000036541 health Effects 0.000 abstract description 13
- 240000000031 Achyranthes bidentata Species 0.000 abstract description 12
- 230000027939 micturition Effects 0.000 abstract description 8
- 206010010774 Constipation Diseases 0.000 abstract description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 4
- 210000003414 extremity Anatomy 0.000 abstract description 4
- 206010022437 insomnia Diseases 0.000 abstract description 4
- 206010000060 Abdominal distension Diseases 0.000 abstract description 3
- 241001061264 Astragalus Species 0.000 abstract description 3
- 208000002173 dizziness Diseases 0.000 abstract description 3
- 210000004233 talus Anatomy 0.000 abstract description 3
- 208000024827 Alzheimer disease Diseases 0.000 abstract description 2
- 244000301850 Cupressus sempervirens Species 0.000 abstract description 2
- 206010028372 Muscular weakness Diseases 0.000 abstract description 2
- 206010039966 Senile dementia Diseases 0.000 abstract description 2
- 210000004556 brain Anatomy 0.000 abstract description 2
- 230000002490 cerebral effect Effects 0.000 abstract description 2
- 230000036473 myasthenia Effects 0.000 abstract description 2
- 239000003053 toxin Substances 0.000 abstract description 2
- 231100000765 toxin Toxicity 0.000 abstract description 2
- 229920002477 rna polymer Polymers 0.000 abstract 2
- 206010033799 Paralysis Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 239000000686 essence Substances 0.000 description 14
- 230000001737 promoting effect Effects 0.000 description 12
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 241000219173 Carica Species 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 241000092665 Atractylodes macrocephala Species 0.000 description 6
- 241000336291 Cistanche deserticola Species 0.000 description 6
- 235000018958 Gardenia augusta Nutrition 0.000 description 6
- 208000004998 Abdominal Pain Diseases 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 241000972673 Phellodendron amurense Species 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 240000006432 Carica papaya Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000031361 Hiccup Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 239000002389 essential drug Substances 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000000409 membrane extraction Methods 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 208000024765 knee pain Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种养生中药组合物,涉及中药组合物技术领域,旨在针对RNA进行养生,用于养生,技术方案是:包括以下重量份数的配制用料:黄芪提取物600份,党参提取物、丹参提取物、白术提取物、黄柏提取物、苍术提取物、菟丝子提取物、肉苁蓉提取物、怀牛膝提取物、沉香提取物、人参提取物、栀子提取物、木瓜提取物、肉桂提取物、甘草提取物均为400份;本发明通过对黄芪、党参、丹参、白术、黄柏、苍术、菟丝子、肉苁蓉、怀牛膝、沉香、人参、栀子、木瓜、肉桂、甘草的提取物进行配比,成品能够培养元气,养育心脑血管,导滞祛湿排毒,养颜健身,并对失眠多梦,四肢无力,头晕脑胀,腹胀,便秘,尿频尿急,老年痴呆,中风和瘫痪起作用。
Description
技术领域
本发明涉及中药组合物技术领域,具体为一种养生中药组合物。
背景技术
任何生命体都由细胞组成,细胞消长体现生命体的健康状况,DNA决定了性别,RNA决定细胞的消长,即为生命基因密码,RNA养生法就是培育生命体康健细胞消长平衡,推进RNA正常生长,达到健康长寿的目的。RNA养生法是一种运用传统中医药学说,依据药食同源规则建立的***化养生方法,它具有预防和养育共同属性,是必须的一门实用科学技术,按阴阳五行平衡要求必须达到如下要求:1、促进消化,2、保肝,3、提高免疫力,4、提高抗疲劳能力包括增强肾上腺素皮质,5、增强造血,降血糖能力,6、抗氧化延缓衰老,7、抗凝血,抗肿瘤,抗菌,扩张血管抑制子宫收缩,8、利尿。
根据RNA养生法基础理论,人体组织细胞繁衍通常可达120年,但人的寿命能不能达到长寿百岁,取决于两个基本要素,即是先天遗传基因和后天获得性环境,前者不可选择,而后者可以获得性养育,通过养生培育细胞的获得性环境。DNA人们了解较多,RNA少数人知,是细胞染色体中端粒体的简称,它决定细胞***次数,决定着生命長短,细胞每***一次缩短一次,一般人在50次左右。由于种种原因便出现黃帝内经所述女人七五头发变白,脸皮变黄,男人五八牙齿松动,虽然无病无痛,但退行性变化趋势日益出现,警示人们养生的迫切性需求,养生方法千千万万,RNA养生方法是壮健细胞衍生息,缓慢退行性变化,目的达到少病痛,延年益寿。因此,发明一种可以针对RNA进行养生的中药组合物是势在必行的。
发明内容
鉴于现有技术中所存在的问题,本发明公开了一种养生中药组合物,采用的技术方案是,包括以下重量份数的配制用料:黄芪提取物600份,黄芪具有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用,党参提取物400份,丹参提取物400份,白术提取物400份,黄柏提取物400份,苍术提取物400份,菟丝子提取物400份,肉苁蓉提取物400份,怀牛膝提取物400份,沉香提取物400份,人参提取物400份,栀子提取物400份,木瓜提取物400份,肉桂提取物400份,甘草提取物400份,党参具有补中益气,健脾益肺之功效,党参有增强免疫力、扩张血管、降压、改善微循环、增强造血功能等作用;丹参为强壮性通经剂,有祛瘀、生新、活血、调经等效用,为妇科要药,主治子宫出血,***,血瘀,腹痛,经痛,经闭,庙痛,对治疗冠心病有良好效果,此外亦治神经性衰弱失眠,关节痛,贫血,乳腺炎,淋巴腺炎,关节炎,疮疖痛肿,丹毒,急慢性肝炎,肾孟肾炎,跌打损伤,晚期血吸虫病肝脾肿大,癫癎,外用又可洗漆疮;白术具有健脾益气,燥湿利水,止汗,安胎的功效,用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安;黄柏,清热解毒,泻火燥湿,主治急性细菌性痢疾、急性肠炎、急性黄疸型肝炎、泌尿***感染等炎症,外用治火烫伤、中耳炎、急性结膜炎等;苍术有燥湿、化浊、止痛之效;菟丝子具有滋补肝肾、固精缩尿、安胎、明目、止泻之功效;肉苁蓉补肾阳,益精血,润肠道;怀牛膝可以补肝益肾、强壮筋骨、通经络、散恶血,临床常用于治疗寒湿,腰膝骨疼、腰膝酸软,四肢拘挛、经血不调、产后瘀血腹疼、血淋、跌打损伤及屈膝碍等症;沉香治气逆喘息,呕吐呃逆,脘腹胀痛,腰膝虚冷,大肠虚秘,小便气淋,男子精冷;人参对神经***,心血管***,内分泌***,消化***,生殖***,呼吸***及外科使用等都有明显的作用;栀子具有护肝、利胆、降压、镇静、止血、消肿等作用;木瓜具有食疗作用,对女性有美容功效;肉桂补元阳,暖脾胃,除积冷,通血脉;甘草主治清热解毒、祛痰止咳、脘腹等,上述各种原料采用膜提取分离技术进行提取并得到相应的提取物,通过这种方式进行提取,选择性分离强,对杂质分离彻底,大大减少了溶剂的消耗,降低防爆等级,提高生产安全,常温浓缩,不破坏热敏性成分,可脱盐降灰份,同时节能降耗,料液以独特的错流式运行方式,无须添加助滤剂,可解决污染堵塞难题,纯物理过程,无化学反应,不改变药效成分,产品品质大大提高,可以减少服用量,降低不良反应,简化工序,缩短周期,提高生产效率,先进的组件化设计,膜材料更换方便,操作简单,自动化控制,设计在线再生清洗和排污,降低劳动强度,实现清洁生产。
作为本发明的一种优选技术方案,包括以下重量的配制用料:黄芪提取物600mg,党参提取物400mg,丹参提取物400mg,白术提取物400mg,黄柏提取物400mg,苍术提取物400mg,菟丝子提取物400mg,肉苁蓉提取物400mg,怀牛膝提取物400mg,沉香提取物400mg,人参提取物400mg,栀子提取物400mg,木瓜提取物400mg,肉桂提取物400mg,甘草提取物400mg,作为精华素。
作为本发明的一种优选技术方案,从20g黄芪中提取出所述黄芪提取物,并从中称量出600mg,作为精华素。
作为本发明的一种优选技术方案,从8g沉香中提取出所述沉香提取物,从8g甘草中提取处所述甘草提取物,并从所述沉香提取物和所述甘草提取物中均称量出400mg,作为精华素。
作为本发明的一种优选技术方案,从10g黄柏提取出所述黄柏提取物,从10g菟丝子中提取出所述菟丝子提取物,并从所述黄柏提取物、所述菟丝子提取物中均称量出400mg,作为精华素。
作为本发明的一种优选技术方案,从12g党参中提取出所述党参提取物,从12g丹参中提取出所述丹参提取物,从12g怀牛膝中提取出所述怀牛膝提取物,从12g栀子中提取出所述栀子提取物,从12g肉桂中提取处所述肉桂提取物,并从所述党参提取物、所述丹参提取物、所述怀牛膝提取物、所述栀子提取物、所述肉桂提取物中均称量出400mg,作为精华素。
作为本发明的一种优选技术方案,从15g白术中提取出所述白术提取物,从15g苍术中提取出所述苍术提取物,从15g肉苁蓉中提取出所述肉苁蓉提取物,从15g人参中提取出所述人参提取物,从15g木瓜中提取出所述木瓜提取物,并从所述白术提取物、所述苍术提取物、所述肉苁蓉提取物、所述人参提取物、所述木瓜提取物中均称量出400mg,作为精华素。
本发明的有益效果:本发明通过对一定重量份的黄芪提取物、党参提取物、丹参提取物、白术提取物、黄柏提取物、苍术提取物、菟丝子提取物、肉苁蓉提取物、怀牛膝提取物、沉香提取物、人参提取物、栀子提取物、木瓜提取物、肉桂提取物、甘草提取物进行混合配制,最终得到的中药组合物不仅能够培养元气,养育心脑血管,导滞祛湿排毒,养颜健身,还能够对失眠多梦,四肢无力,头晕脑胀,腹胀,便秘,尿频尿急,预防老年痴呆起作用,综上所述,可以确定本中药组合物属于三防素,即能够防痴呆,防中风,防瘫痪。
具体实施方式
实施例1
本发明公开了一种养生中药组合物,采用的技术方案是,包括以下重量份数的配制用料:黄芪提取物600份,在该养生中药组合物中起的主要作用是,增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压、抗菌,党参提取物400份,丹参提取物400份,白术提取物400份,黄柏提取物400份,苍术提取物400份,菟丝子提取物400份,肉苁蓉提取物400份,怀牛膝提取物400份,沉香提取物400份,人参提取物400份,栀子提取物400份,木瓜提取物400份,肉桂提取物400份,甘草提取物400份,在该养生中药组合物中各个原料所起的作用各有不同之处,党参可以补中益气,健脾益肺,同时还能够增强免疫力、扩张血管、降压、改善微循环、增强造血功能;丹参有祛瘀、生新、活血、调经等效用,为妇科要药,主治子宫出血,***,血瘀,腹痛,经痛,经闭,庙痛,对治疗冠心病有良好效果,此外亦治神经性衰弱失眠;白术具有健脾益气的功效,可用于脾虚食少,腹胀泄泻;黄柏清热解毒,泻火燥湿,主治多种炎症;苍术有燥湿、化浊、止痛之效;菟丝子具有滋补肝肾、固精缩尿、明目、止泻的功效;肉苁蓉补肾阳,益精血,润肠道;怀牛膝可以补肝益肾、强壮筋骨、通经络、散恶血,常用于治疗腰膝骨疼、腰膝酸软,四肢拘挛等症;沉香治气逆喘息,呕吐呃逆,脘腹胀痛,腰膝虚冷,大肠虚秘,小便气淋;人参对对人体内的各种***及外科使用等都有明显的作用;栀子具有护肝、利胆、降压、镇静、止血、消肿等作用;木瓜具有食疗作用,对女性有美容功效;肉桂补元阳,暖脾胃,除积冷,通血脉;甘草主治清热解毒、祛痰止咳、脘腹等,上述各种原料采用膜提取分离技术进行提取并得到相应的提取物,通过这种方式进行提取,可对杂质进行选择分离,减少了溶剂和能量的消耗,不易污染堵塞,同时纯物理的提取过程,可以保持药效成分,工序得到了简化,生产周期缩短,生产效率提高,膜材料更换方便,操作简单,便于清洗和排污,工作人员劳动强度降低。
作为本发明的一种优选技术方案,包括以下重量的配制用料:黄芪提取物600mg,党参提取物400mg,丹参提取物400mg,白术提取物400mg,黄柏提取物400mg,苍术提取物400mg,菟丝子提取物400mg,肉苁蓉提取物400mg,怀牛膝提取物400mg,沉香提取物400mg,人参提取物400mg,栀子提取物400mg,木瓜提取物400mg,肉桂提取物400mg,甘草提取物400mg,作为精华素。
作为本发明的一种优选技术方案,从20g黄芪中提取出所述黄芪提取物,并从中称量出600mg,作为精华素。
作为本发明的一种优选技术方案,从8g沉香中提取出所述沉香提取物,从8g甘草中提取处所述甘草提取物,并从所述沉香提取物和所述甘草提取物中均称量出400mg,作为精华素。
作为本发明的一种优选技术方案,从10g黄柏提取出所述黄柏提取物,从10g菟丝子中提取出所述菟丝子提取物,并从所述黄柏提取物、所述菟丝子提取物中均称量出400mg,作为精华素。
作为本发明的一种优选技术方案,从12g党参中提取出所述党参提取物,从12g丹参中提取出所述丹参提取物,从12g怀牛膝中提取出所述怀牛膝提取物,从12g栀子中提取出所述栀子提取物,从12g肉桂中提取处所述肉桂提取物,并从所述党参提取物、所述丹参提取物、所述怀牛膝提取物、所述栀子提取物、所述肉桂提取物中均称量出400mg,作为精华素。
作为本发明的一种优选技术方案,从15g白术中提取出所述白术提取物,从15g苍术中提取出所述苍术提取物,从15g肉苁蓉中提取出所述肉苁蓉提取物,从15g人参中提取出所述人参提取物,从15g木瓜中提取出所述木瓜提取物,并从所述白术提取物、所述苍术提取物、所述肉苁蓉提取物、所述人参提取物、所述木瓜提取物中均称量出400mg,作为精华素。
上述虽然对本发明的具体实施例作了详细说明,但是本发明并不限于上述实施例,在本领域普通技术人员所具备的知识范围内,还可以在不脱离本发明宗旨的前提下做出各种变化,而不具备创造性劳动的修改或变形仍在本发明的保护范围以内。
Claims (7)
1.一种养生中药组合物,其特征在于,包括以下重量份数的配制用料:黄芪提取物600份,党参提取物400份,丹参提取物400份,白术提取物400份,黄柏提取物400份,苍术提取物400份,菟丝子提取物400份,肉苁蓉提取物400份,怀牛膝提取物400份,沉香提取物400份,人参提取物400份,栀子提取物400份,木瓜提取物400份,肉桂提取物400份,甘草提取物400份。
2.根据权利要求1所述的一种养生中药组合物,其特征在于:包括以下重量的配制用料:黄芪提取物600mg,党参提取物400mg,丹参提取物400mg,白术提取物400mg,黄柏提取物400mg,苍术提取物400mg,菟丝子提取物400mg,肉苁蓉提取物400mg,怀牛膝提取物400mg,沉香提取物400mg,人参提取物400mg,栀子提取物400mg,木瓜提取物400mg,肉桂提取物400mg,甘草提取物400mg。
3.根据权利要求2所述的一种养生中药组合物,其特征在于:从20g黄芪中提取出所述黄芪提取物,并从中称量出600mg。
4.根据权利要求2所述的一种养生中药组合物,其特征在于:从8g沉香中提取出所述沉香提取物,从8g甘草中提取处所述甘草提取物,并从所述沉香提取物和所述甘草提取物中均称量出400mg。
5.根据权利要求2所述的一种养生中药组合物,其特征在于:从10g黄柏提取出所述黄柏提取物,从10g菟丝子中提取出所述菟丝子提取物,并从所述黄柏提取物、所述菟丝子提取物中均称量出400mg。
6.根据权利要求2所述的一种养生中药组合物,其特征在于:从12g党参中提取出所述党参提取物,从12g丹参中提取出所述丹参提取物,从12g怀牛膝中提取出所述怀牛膝提取物,从12g栀子中提取出所述栀子提取物,从12g肉桂中提取处所述肉桂提取物,并从所述党参提取物、所述丹参提取物、所述怀牛膝提取物、所述栀子提取物、所述肉桂提取物中均称量出400mg。
7.根据权利要求2所述的一种养生中药组合物,其特征在于:从15g白术中提取出所述白术提取物,从15g苍术中提取出所述苍术提取物,从15g肉苁蓉中提取出所述肉苁蓉提取物,从15g人参中提取出所述人参提取物,从15g木瓜中提取出所述木瓜提取物,并从所述白术提取物、所述苍术提取物、所述肉苁蓉提取物、所述人参提取物、所述木瓜提取物中均称量出400mg。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210245860.6A CN114470069A (zh) | 2022-03-17 | 2022-03-17 | 一种养生中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210245860.6A CN114470069A (zh) | 2022-03-17 | 2022-03-17 | 一种养生中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114470069A true CN114470069A (zh) | 2022-05-13 |
Family
ID=81486942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210245860.6A Pending CN114470069A (zh) | 2022-03-17 | 2022-03-17 | 一种养生中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114470069A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102631595A (zh) * | 2012-05-15 | 2012-08-15 | 云南中医学院 | 治疗2型糖尿病的药物及其制备方法 |
CN109925384A (zh) * | 2017-12-19 | 2019-06-25 | 杨岳燕 | 一种能够提升抗衰弱能力的中药汤剂 |
-
2022
- 2022-03-17 CN CN202210245860.6A patent/CN114470069A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102631595A (zh) * | 2012-05-15 | 2012-08-15 | 云南中医学院 | 治疗2型糖尿病的药物及其制备方法 |
CN109925384A (zh) * | 2017-12-19 | 2019-06-25 | 杨岳燕 | 一种能够提升抗衰弱能力的中药汤剂 |
Non-Patent Citations (2)
Title |
---|
季荣平: "辨证分型治疗慢性泄泻100例临床观察", 《湖南中医杂志》 * |
金燕会 等: "调补脾胃法在内科临床的应用", 《北京中医》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104689012A (zh) | 一种补肾壮骨酒及其制备方法 | |
CN104547486A (zh) | 一种用于治疗贫血、气虚乏力的中药制剂及其制备工艺 | |
CN104491801A (zh) | 一种治疗急慢性胃炎的中药制剂及其制备方法 | |
CN107789484B (zh) | 一种治疗***的中药组合物及其制备方法 | |
CN104721649A (zh) | 一种治疗内分泌失调的中药 | |
CN104225166A (zh) | 一种治疗闭经的中药组合物及其制备方法 | |
CN104491802A (zh) | 一种中药制剂在制备治疗急慢性胃炎药物中的用途 | |
CN104491236A (zh) | 一种治疗原发性高血压的中药制剂及其制备方法 | |
CN104306540A (zh) | 一种治疗脑瘤术后肢体麻木的中药制剂及其制备方法 | |
CN102100873B (zh) | 一种治疗心脑血管病的中成药及其制备方法 | |
CN102357228B (zh) | 一种治疗肝病的中药组合物 | |
CN104257883A (zh) | 一种治疗化疗后白细胞减少症的中药组合物 | |
CN114470069A (zh) | 一种养生中药组合物 | |
CN103356870B (zh) | 一种治疗产后缺乳的中药制剂及制备方法 | |
CN1045893C (zh) | 一种治疗妇女子宫肌瘤的药物 | |
CN104984027A (zh) | 一种治疗骨髓增生异常综合征的中药制剂及其制备方法 | |
CN102100826A (zh) | 一种治疗犬细小病毒性肠炎的中药复方制剂及其制备方法 | |
CN105250569A (zh) | 一种用于治疗末梢神经炎的中药丸剂及制备方法 | |
CN111166825A (zh) | 一种治疗早期高血压阴虚性中风偏瘫的药物及其制备方法 | |
CN104208251A (zh) | 一种抗艾滋病病毒的复方中药合剂及其配制方法 | |
CN104547474B (zh) | 一种中药制剂在制备治疗肝癌药物中的用途 | |
CN103520631B (zh) | 一种治疗***的中药 | |
CN105456447A (zh) | 一种含有艾叶的具有活血化淤功能的中药组合物及其制备方法 | |
CN103990010A (zh) | 治疗癌症的药物组合及制备方法 | |
CN105456933A (zh) | 一种活血化瘀、通经活络的中药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220513 |